Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies

MLA

H. Nakajima, et al. “Nonmyeloablative Stem Cell Transplantation with Fludarabine and Cyclophosphamide for Patients with Hematologic Malignancies.” Clinical & Laboratory Haematology, vol. 25, Nov. 2003, pp. 383–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ddc62f03f7f8a61d1b96f4a78cfd2c60&authtype=sso&custid=ns315887.

APA

H. Nakajima, A. Yokota, Yuji Tanaka, T. Sakura, Shin Ichiro Mori, Hisashi Sakamaki, Kishi K, Nahoko Hatsumi, Jun-ichi Ueyama, S. Miyawaki, Shin Fujisawa, Masayuki Oki, & Shigesaburo Miyakoshi. (2003). Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies. Clinical & Laboratory Haematology, 25, 383–391.

Chicago

H. Nakajima, A. Yokota, Yuji Tanaka, T. Sakura, Shin Ichiro Mori, Hisashi Sakamaki, Kishi K, et al. 2003. “Nonmyeloablative Stem Cell Transplantation with Fludarabine and Cyclophosphamide for Patients with Hematologic Malignancies.” Clinical & Laboratory Haematology 25 (November): 383–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ddc62f03f7f8a61d1b96f4a78cfd2c60&authtype=sso&custid=ns315887.